|
August
1999
Second Wind
Lomita, California
Dear Friends:
The 42nd Aspen Lung Conference,
held in June, 1999, offered new insights into the mechanisms involved
in the development of COPD. These Conferences began in 1958 and
were initiated to try to understand the basic nature of emphysema
and chronic bronchitis, which today we lump together under the
designation of COPD. In the 41-years that have followed, we now
recognized that COPD has both susceptibility factors in the patient
(host), and inciting environmental factors which trigger inflammatory
mechanisms which attack alveoli and small airways. Alveoli contain
the elastic fibers that allow the lungs to fill in an orderly
fashion and to empty during exhalation. Alveoli also attach to
small airways and tether them, thus keeping them open during the
expiratory phase of respiration. An attack on alveoli appears
to come from enzymes, (elastases), which are released from white
cells, when stimulated by tobacco smoke and other irritants. When
small airways are attacked they become inflamed and overreact
with a degree of bronchospasm, in some ways similar to asthma.
Tobacco smoke also creates oxidants which destroy protective material
in the lung known as antiproteases, so that destructive enzymes
become unopposed and do their damage to small lung units.
Although COPD clusters in families,
the exact genetic defect or defects remain unknown. Certainly
these familial risks go beyond the rare but important alpha antitrypsin
deficiency state, (AAT).
How to protect the lung from elastase,
oxidative, as well as other damages was considered at the Conference.
Antioxidants in food may play a protective role. Drugs known as
isoretinines may help restore the alveoli in an experimental model
of emphysema. Whether the same will be true in humans is a subject
of current study.
The most effective way to prevent
or to forestall COPD is to avoid all tobacco smoke, both active
and passive. Eating a diet rich in antioxidant vitamins and protective
fish oils is probably wise. Understanding the mechanisms of COPD
forms a foundation for new therapies. New drugs are on the horizon
which may help reduce or eliminate the damage that today results
in COPD, the only major disease amongst the top ten killers that
continues to rise. Progress is being made, and the future looks
bright.
Your friend,

Thomas Petty, MD
|